Base Pay. The Company agrees to pay Executive gross annual compensation of $240,000 (“Base Salary”), less usual and customary withholdings, which shall be payable in arrears in accordance with the Company’s customary payroll practices. The Base Salary will be subject to normal periodic review, and such review will consider Executive’s contributions to the Company and the Company’s overall performance.
Appears in 4 contracts
Sources: Employment Agreement (DiaMedica Therapeutics Inc.), Employment Agreement (DiaMedica Therapeutics Inc.), Employment Agreement (DiaMedica Therapeutics Inc.)
Base Pay. The Company agrees to pay Executive Employee gross annual compensation of $240,000 400,000 (“Base Salary”), less usual and customary withholdings, which shall be payable in arrears in accordance with the Company’s customary payroll practices. The Base Salary will be subject to normal periodic review, and such review will consider ExecutiveEmployee’s contributions to the Company and the Company’s overall performance.
Appears in 4 contracts
Sources: Employment Agreement (Xtant Medical Holdings, Inc.), Employment Agreement (Xtant Medical Holdings, Inc.), Employment Agreement (Xtant Medical Holdings, Inc.)
Base Pay. The Company agrees to pay Executive gross annual compensation of $240,000 345,000 (“Base Salary”), less usual and customary withholdings, which shall be payable in arrears in accordance with the Company’s customary payroll practices. The Base Salary will be subject to normal periodic review, and such review will consider Executive’s contributions to the Company and the Company’s overall performance.
Appears in 2 contracts
Sources: Employment Agreement (DiaMedica Therapeutics Inc.), Employment Agreement (DiaMedica Therapeutics Inc.)
Base Pay. The Company agrees to pay Executive gross annual compensation of $240,000 425,000 (“Base Salary”), less usual and customary withholdings, which shall be payable in arrears in accordance with the Company’s customary payroll practices. The Base Salary will be subject to normal periodic review, and such review will consider Executive’s contributions to the Company and the Company’s overall performance.
Appears in 1 contract
Base Pay. The Company agrees to pay Executive gross annual compensation of $240,000 380,000 (“Base Salary”), less usual and customary withholdings, which shall be payable in arrears in accordance with the Company’s customary payroll practices. The Base Salary will be subject to normal periodic review, and such review will consider Executive’s contributions to the Company and the Company’s overall performance.
Appears in 1 contract
Base Pay. The During Executive’s employment hereunder, the Company agrees to pay Executive gross annual compensation of $240,000 525,000 (“Base Salary”), less usual and customary withholdings, which shall be payable in arrears in accordance with the Company’s customary payroll practices. The Base Salary will be subject to normal periodic review, and such review will consider Executive’s contributions to the Company and the Company’s overall performance.
Appears in 1 contract
Sources: Interim Executive Employment Agreement (Xtant Medical Holdings, Inc.)